PT1465608E - Composições de libertação prolongada compreendendo como composto activo hidrocloreto de venlafaxina - Google Patents

Composições de libertação prolongada compreendendo como composto activo hidrocloreto de venlafaxina Download PDF

Info

Publication number
PT1465608E
PT1465608E PT02785879T PT02785879T PT1465608E PT 1465608 E PT1465608 E PT 1465608E PT 02785879 T PT02785879 T PT 02785879T PT 02785879 T PT02785879 T PT 02785879T PT 1465608 E PT1465608 E PT 1465608E
Authority
PT
Portugal
Prior art keywords
venlafaxine hydrochloride
active compound
extended release
release compositions
coated
Prior art date
Application number
PT02785879T
Other languages
English (en)
Inventor
Yoram Sela
Original Assignee
Krka Tovarna Zdravil D D Novo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11075859&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1465608(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Krka Tovarna Zdravil D D Novo filed Critical Krka Tovarna Zdravil D D Novo
Publication of PT1465608E publication Critical patent/PT1465608E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT02785879T 2001-11-13 2002-11-07 Composições de libertação prolongada compreendendo como composto activo hidrocloreto de venlafaxina PT1465608E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL146462A IL146462A (en) 2001-11-13 2001-11-13 Prolonged-release preparations containing as an active compound and analapaxin hydrochloride

Publications (1)

Publication Number Publication Date
PT1465608E true PT1465608E (pt) 2009-07-23

Family

ID=11075859

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02785879T PT1465608E (pt) 2001-11-13 2002-11-07 Composições de libertação prolongada compreendendo como composto activo hidrocloreto de venlafaxina

Country Status (11)

Country Link
US (2) US8062666B2 (pt)
EP (1) EP1465608B1 (pt)
AT (1) ATE429907T1 (pt)
CA (1) CA2473200C (pt)
DE (1) DE60232189D1 (pt)
HU (1) HUP0500540A3 (pt)
IL (1) IL146462A (pt)
PT (1) PT1465608E (pt)
RU (1) RU2314798C2 (pt)
SI (1) SI1465608T1 (pt)
WO (1) WO2003041692A1 (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL146462A (en) 2001-11-13 2015-02-26 Lycored Bio Ltd Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
AU2003236947A1 (en) * 2002-06-07 2003-12-22 Ranbaxy Laboratories Limited Modified release, multiple unit drug delivery systems
WO2004047718A2 (en) * 2002-11-28 2004-06-10 Themis Laboratories Private Limited Process for manufacturing sustained release microbeads containing venlafaxine hci
CN100348105C (zh) * 2003-10-01 2007-11-14 巴斯福股份公司 杀真菌剂混合物
HUP0303382A2 (hu) * 2003-10-10 2005-08-29 EGIS Gyógyszergyár Rt. Venlafaxin-hidroklorid-tartalmú pelletek
US7470435B2 (en) 2003-11-17 2008-12-30 Andrx Pharmaceuticals, Llc Extended release venlafaxine formulation
US7888412B2 (en) 2004-03-26 2011-02-15 Board Of Trustees Of The University Of Alabama Polymer dissolution and blend formation in ionic liquids
DE102004036641A1 (de) * 2004-07-28 2006-03-23 Krka Tovarna Zdravil, D.D. Verzögert freisetzende pharmazeutische Zusammensetzung, die Venlafaxin enthält
US7550520B2 (en) 2005-05-31 2009-06-23 The University Of Alabama Method of preparing high orientation nanoparticle-containing sheets or films using ionic liquids, and the sheets or films produced thereby
US8883193B2 (en) 2005-06-29 2014-11-11 The University Of Alabama Cellulosic biocomposites as molecular scaffolds for nano-architectures
ITFI20050206A1 (it) * 2005-09-30 2007-04-01 Valpharma Sa Composizione farmaceutica a rilascio controllato di venlafaxina cloridrato, e processo per la sua preparazione
EP1954669B1 (en) * 2005-12-01 2015-07-08 Auspex Pharmaceuticals, Inc. Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
US7427414B2 (en) * 2006-01-18 2008-09-23 Astron Research Limited Modified release oral dosage form using co-polymer of polyvinyl acetate
WO2007129329A2 (en) * 2006-05-08 2007-11-15 Jubilant Organosys Limited Extended release pharmaceutical formulation comprising venlafaxine hydrochloride
US20080081067A1 (en) * 2006-10-03 2008-04-03 Gupta Manishkumar Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof
HUE031070T2 (en) * 2007-03-15 2017-06-28 Auspex Pharmaceuticals Inc Deuterated d9-venlafaxine
WO2009105236A1 (en) 2008-02-19 2009-08-27 The Board Of Trustees Of The University Of Alabama Ionic liquid systems for the processing of biomass, their components and/or derivatives, and mixtures thereof
WO2010078300A1 (en) 2008-12-29 2010-07-08 The Board Of Trustees Of The University Of Alabama Dual functioning ionic liquids and salts thereof
US9096743B2 (en) 2009-06-01 2015-08-04 The Board Of Trustees Of The University Of Alabama Process for forming films, fibers, and beads from chitinous biomass
US8784691B2 (en) 2009-07-24 2014-07-22 Board Of Trustees Of The University Of Alabama Conductive composites prepared using ionic liquids
US9394375B2 (en) 2011-03-25 2016-07-19 Board Of Trustees Of The University Of Alabama Compositions containing recyclable ionic liquids for use in biomass processing
WO2014012063A1 (en) * 2012-07-12 2014-01-16 Psyadon Pharmaceuticals, Inc. Pharmaceutical dosage forms comprising ecopipam free base or pharmaceutically acceptable salts thereof
US10100131B2 (en) 2014-08-27 2018-10-16 The Board Of Trustees Of The University Of Alabama Chemical pulping of chitinous biomass for chitin
US10011931B2 (en) 2014-10-06 2018-07-03 Natural Fiber Welding, Inc. Methods, processes, and apparatuses for producing dyed and welded substrates
US10982381B2 (en) 2014-10-06 2021-04-20 Natural Fiber Welding, Inc. Methods, processes, and apparatuses for producing welded substrates
CA3001495C (en) * 2014-11-03 2021-07-20 Solipharma Llc Formulations of dabigatran etexilate or dabigatran etexilate salts and preparation methods thereof
CN114657730A (zh) 2016-03-25 2022-06-24 天然纤维焊接股份有限公司 用于生产焊接基质的方法、工艺和设备
JP7114484B2 (ja) 2016-05-03 2022-08-08 ナチュラル ファイバー ウェルディング インコーポレーテッド 染色及び溶着された基材を製造するための方法、プロセス、及び装置
US10927191B2 (en) 2017-01-06 2021-02-23 The Board Of Trustees Of The University Of Alabama Coagulation of chitin from ionic liquid solutions using kosmotropic salts
US10941258B2 (en) 2017-03-24 2021-03-09 The Board Of Trustees Of The University Of Alabama Metal particle-chitin composite materials and methods of making thereof
CN112089706A (zh) * 2020-09-28 2020-12-18 深圳雾件科技有限公司 一种烟酰胺单核苷酸缓释微丸及其制备方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4521401A (en) * 1983-01-03 1985-06-04 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of quinidine
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
IE60311B1 (en) * 1987-09-24 1994-06-29 American Home Prod Sustained release etodolac
DE69111287T2 (de) * 1990-04-18 1995-12-21 Asahi Chemical Ind Kugelförmige Keimkerne, kugelförmige Granulate sowie Verfahren zu deren Herstellung.
US5232706A (en) * 1990-12-31 1993-08-03 Esteve Quimica, S.A. Oral pharmaceutical preparation containing omeprazol
US5472712A (en) * 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
PE57198A1 (es) 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
US6274171B1 (en) * 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
UA56257C2 (uk) 1997-09-23 2003-05-15 Елі Ліллі Енд Компані Спосіб лікування неадекватної визивної поведінки
UA77145C2 (en) * 1997-11-05 2006-11-15 Wyeth Corp Extended release dosage formulation
CN1203846C (zh) * 1998-03-19 2005-06-01 布里斯托尔-迈尔斯斯奎布公司 高溶解性药物的双相控释递送系统和方法
US5997905A (en) * 1998-09-04 1999-12-07 Mcneil-Ppc Preparation of pharmaceutically active particles
DE19901686A1 (de) * 1999-01-18 2000-07-20 Gruenenthal Gmbh Retardierte Tramadolzubereitungen mit einem lagerstabilen Freisetzungsprofil und Verfahren zu deren Herstellung
DK1178780T3 (da) * 1999-05-20 2007-11-12 Elan Corp Plc Multipartikelformige formuleringer til kontrolleret frigivelse af selektiv serotoningenoptagelseshæmmer
AU7581800A (en) 1999-09-14 2001-04-17 Smithkline Beecham Corporation Process for making aqueous coated beadlets
BR0100334A (pt) * 2001-01-17 2002-09-24 Diffucap Chemobras Quimica E F Processo para a preparação de composições de liberação programada contendo venlafaxina e o produto resultante
IL146462A (en) 2001-11-13 2015-02-26 Lycored Bio Ltd Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
IL149055A0 (en) * 2002-04-09 2002-11-10 Karma Pharm Ltd Extended release composition comprising as active compound venlafaxine hydrochloride
US6703044B1 (en) * 2002-10-25 2004-03-09 Dexcel Pharma Tech, Ltd Venlafaxine formulations
WO2004047718A2 (en) 2002-11-28 2004-06-10 Themis Laboratories Private Limited Process for manufacturing sustained release microbeads containing venlafaxine hci
TW200503670A (en) 2003-03-28 2005-02-01 Sandoz Ag Venlafaxine compositions
DK1502587T3 (da) 2003-07-30 2007-01-02 Pharmathen Sa Formulering med vedvarende frigivelse af venlafaxinhydrochlorid
HUP0303382A2 (hu) 2003-10-10 2005-08-29 EGIS Gyógyszergyár Rt. Venlafaxin-hidroklorid-tartalmú pelletek
US7470435B2 (en) * 2003-11-17 2008-12-30 Andrx Pharmaceuticals, Llc Extended release venlafaxine formulation
KR20070000439A (ko) 2004-02-04 2007-01-02 알렘빅 리미티드 벤라팍신 히드로클로라이드의 방출연장형 코팅 미니정제
FR2919611B1 (fr) * 2007-08-03 2009-10-23 Bio Rad Pasteur Sa Nouvel epitope du bnp (1-32) et anticorps diriges contre cet epitope

Also Published As

Publication number Publication date
HUP0500540A2 (hu) 2005-09-28
SI1465608T1 (sl) 2009-10-31
US20050118264A1 (en) 2005-06-02
RU2004121786A (ru) 2005-04-20
US20130115298A2 (en) 2013-05-09
EP1465608A1 (en) 2004-10-13
US20120135082A1 (en) 2012-05-31
IL146462A (en) 2015-02-26
CA2473200C (en) 2011-09-20
CA2473200A1 (en) 2003-05-22
WO2003041692A1 (en) 2003-05-22
DE60232189D1 (de) 2009-06-10
US8062666B2 (en) 2011-11-22
HUP0500540A3 (en) 2008-03-28
ATE429907T1 (de) 2009-05-15
EP1465608B1 (en) 2009-04-29
US8557282B2 (en) 2013-10-15
RU2314798C2 (ru) 2008-01-20
US20100330178A2 (en) 2010-12-30

Similar Documents

Publication Publication Date Title
SI1465608T1 (sl) Sestavki s podaljšanim sproščanjem, ki obsegajo kot aktivno spojino venlafaksin hidroklorid
TW200724033A (en) Anthranilamide arthropodicide treatment
WO2008093346A3 (en) Compositions for topical application comprising a peroxide and retinoid
WO2006086271A3 (en) Methods and compositions for biocidal treatments
MY146614A (en) Shading composition
AU2002254036A1 (en) Taste masked pharmaceutical compositions
MX2007006084A (es) Composiciones y metodos de recubrimiento.
HUP0303961A2 (hu) Gombaellenes szert tartalmazó topikális készítmény
WO2006057950A3 (en) 4-phenyl substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
WO2008151460A3 (en) Cooling compounds
IL190305A0 (en) Controlled release, pharmaceutical composition of venlafaxine hydrochloride, and process for preparation thereof
IL149055A0 (en) Extended release composition comprising as active compound venlafaxine hydrochloride
WO2004019683A3 (en) Antimicrobial compositions
WO2001014493A3 (de) Anorganische beschichtungszusammensetzung, ein verfahren zu deren herstellung sowie deren verwendung
AU2002225369A1 (en) Photobase generators, curable compositions prepared by using the same and process of curing
TWI266775B (en) Polyacrylic acid hydrazide and crosslinking or hardening agent for resin
WO2006023586A3 (en) Guanylhydrazone compounds, compositions, methods of making and using
MY156678A (en) Pest controlling composition and method of controlling pest
AU2002221737A1 (en) Antifungal 4-substituted 5,6-dihydro-4h-pyrrolo(1,2-a)(1,4)benzodiazepines
ES2183709A1 (es) Composicion para el control de artropodos.
WO2006005017A3 (en) Oral composition comprising carbamylating agent
BRPI0406734A (pt) Composição termiticida, e, método para controlar térmitas
ATE432336T1 (de) Umhüllte enzymkörnchen
WO2005051362A3 (en) Oral benzimidazole compositions comprising an active core, an optional separating layer and an enteric coating
GB0103046D0 (en) Organic Compounds